Contraindicated (one)pentobarbital will lessen the extent or result of naloxegol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Use of naloxegol with sturdy CYP3A4 inducers is just not advisable pentobarbital will minimize the extent or effect of bosentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unfamiliar. pentobarbital ... https://derekd207vyz6.wikisona.com/user